See the published version of this preprint at BMC Pulmonary Medicine.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research article
Xinwei Han
Zhengzhou University First Affiliated Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-8411-6427
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Endoscopic removal is the most common method for removal of tracheal stents. Few studies have reported the technique of fluoroscopy-guided stent removal for tracheal fistula and tracheal stenosis. We aimed to study the safety and efficacy of fluoroscopy-guided stent removal as well as the optimal duration for stent usage.
Methods: We conducted a retrospective analysis of 152 patients who underwent fluoroscopy-guided stent removal from January 2011 to June 2017. Reasons for stent implantation were tracheal fistula in 85 patients (TF group), and tracheal stenosis in 67 patients (TS group). All patients underwent tracheal CT scans before stent removal and during follow up. The technical success rate, complications, and survival rate were compared between the two groups.
Results: The technical success rate of stent removal was 98.9% and 97.4%, respectively for the TF and TS group. Removal was routine for half of patients, and in the remainder, excessive granulation tissue was the common indications for stent removal, which was found after stenting at 142.1±25.9 days in the TF group, and at 89.9±15.0 day in the TS group. The total incidence of complications was 21.1% and 22.4%, respectively, for the TF and TS groups. Perioperative death occurred in one patient in the TF group, and two patients in the TS group. Recurrence of fistula or stenosis requiring re-stenting was the most comment complication in both groups. The 0.5-, 3-, 6-year survival rates were 90.3%, 59.6%, and 36.1% for TF group, and 80.4%, 75.7%, 75.7% for TS group.
Conclusions: Fluoroscopic removal of tracheal stents is safe and effective for both tracheal fistula and tracheal stenosis, with no significant difference in outcomes. Clinicians should pay attention to the risk of hemoptysis for patients with malignant tumors and a combination with endoscopic hemostasis may help improve its safety.
Keywords
Respiratory tract fistula, Tracheal stenosis, Stents removal, Fluoroscopy, Postoperative complications
Figure 1
Figure 2
Figure 3
This is a list of supplementary files associated with this preprint. Click to download.
- Video1.mp4
Video 1. Stent removal for straight tracheal stent.
- Video2.mp4
Video 2. Stent removal for Y-type tracheal stent.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Pulmonary Medicine.
No community comments so far
Editorial decision: Accept
On 09 Nov, 2020
Editor assigned
On 08 Nov, 2020
Submission checks complete
On 08 Nov, 2020
Editor invited
On 08 Nov, 2020
Version 3
Posted 28 Oct, 2020
No comments provided
Editor assigned
On 22 Oct, 2020
Submission checks complete
On 21 Oct, 2020
Editor invited
On 21 Oct, 2020
No comments provided
Reviewers invited
Invitations sent on 14 Oct, 2020
Reviewer #1 agreed
On 14 Oct, 2020
Editor assigned
On 27 Sep, 2020
Submission checks complete
On 26 Sep, 2020
Editor invited
On 26 Sep, 2020
Version (no preprint)
Posted 26 Feb, 2020
Editorial decision: Major revision
On 15 Sep, 2020
Review #1 received
Received 11 Sep, 2020
Reviewer #1 agreed
On 21 Jul, 2020
Editor assigned
On 20 Jul, 2020
Reviewers invited
Invitations sent on 20 Jul, 2020
Submission checks complete
On 19 Jul, 2020
Editor invited
On 19 Jul, 2020
This version was not preprinted
No comments provided
Review #2 received
Received 17 Jun, 2020
Reviewer #2 agreed
On 03 Jun, 2020
Review #1 received
Received 02 Apr, 2020
Reviewer #1 agreed
On 01 Apr, 2020
Reviewers invited
Invitations sent on 04 Mar, 2020
Editor assigned
On 12 Feb, 2020
First submitted
On 11 Feb, 2020
Submission checks complete
On 11 Feb, 2020
Editor invited
On 11 Feb, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Pulmonology
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
See the published version of this preprint at BMC Pulmonary Medicine.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research article
Xinwei Han
Zhengzhou University First Affiliated Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-8411-6427
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Pulmonary Medicine.
No community comments so far
Editorial decision: Accept
On 09 Nov, 2020
Editor assigned
On 08 Nov, 2020
Submission checks complete
On 08 Nov, 2020
Editor invited
On 08 Nov, 2020
Version 3
Posted 28 Oct, 2020
No comments provided
Editor assigned
On 22 Oct, 2020
Submission checks complete
On 21 Oct, 2020
Editor invited
On 21 Oct, 2020
No comments provided
Reviewers invited
Invitations sent on 14 Oct, 2020
Reviewer #1 agreed
On 14 Oct, 2020
Editor assigned
On 27 Sep, 2020
Submission checks complete
On 26 Sep, 2020
Editor invited
On 26 Sep, 2020
Version (no preprint)
Posted 26 Feb, 2020
Editorial decision: Major revision
On 15 Sep, 2020
Review #1 received
Received 11 Sep, 2020
Reviewer #1 agreed
On 21 Jul, 2020
Editor assigned
On 20 Jul, 2020
Reviewers invited
Invitations sent on 20 Jul, 2020
Submission checks complete
On 19 Jul, 2020
Editor invited
On 19 Jul, 2020
This version was not preprinted
No comments provided
Review #2 received
Received 17 Jun, 2020
Reviewer #2 agreed
On 03 Jun, 2020
Review #1 received
Received 02 Apr, 2020
Reviewer #1 agreed
On 01 Apr, 2020
Reviewers invited
Invitations sent on 04 Mar, 2020
Editor assigned
On 12 Feb, 2020
First submitted
On 11 Feb, 2020
Submission checks complete
On 11 Feb, 2020
Editor invited
On 11 Feb, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Pulmonology
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at BMC Pulmonary Medicine.
Background: Endoscopic removal is the most common method for removal of tracheal stents. Few studies have reported the technique of fluoroscopy-guided stent removal for tracheal fistula and tracheal stenosis. We aimed to study the safety and efficacy of fluoroscopy-guided stent removal as well as the optimal duration for stent usage.
Methods: We conducted a retrospective analysis of 152 patients who underwent fluoroscopy-guided stent removal from January 2011 to June 2017. Reasons for stent implantation were tracheal fistula in 85 patients (TF group), and tracheal stenosis in 67 patients (TS group). All patients underwent tracheal CT scans before stent removal and during follow up. The technical success rate, complications, and survival rate were compared between the two groups.
Results: The technical success rate of stent removal was 98.9% and 97.4%, respectively for the TF and TS group. Removal was routine for half of patients, and in the remainder, excessive granulation tissue was the common indications for stent removal, which was found after stenting at 142.1±25.9 days in the TF group, and at 89.9±15.0 day in the TS group. The total incidence of complications was 21.1% and 22.4%, respectively, for the TF and TS groups. Perioperative death occurred in one patient in the TF group, and two patients in the TS group. Recurrence of fistula or stenosis requiring re-stenting was the most comment complication in both groups. The 0.5-, 3-, 6-year survival rates were 90.3%, 59.6%, and 36.1% for TF group, and 80.4%, 75.7%, 75.7% for TS group.
Conclusions: Fluoroscopic removal of tracheal stents is safe and effective for both tracheal fistula and tracheal stenosis, with no significant difference in outcomes. Clinicians should pay attention to the risk of hemoptysis for patients with malignant tumors and a combination with endoscopic hemostasis may help improve its safety.
Figure 1
Figure 2
Figure 3
This is a list of supplementary files associated with this preprint. Click to download.
- Video1.mp4
Video 1. Stent removal for straight tracheal stent.
- Video2.mp4
Video 2. Stent removal for Y-type tracheal stent.
Loading...